ENSG:NASDAQThe Ensign Group, Inc. Analysis
Data as of 2026-09-01 - not real-time
$174.02
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind The Ensign Group, Inc. is neutral at $174.01, with no clear ordering between short and long averages. Over a rolling month the price has gained 1.8%. With RSI at 43.3 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near $170.00 and resistance around $185.90.
On valuation the read is undervalued — earnings multiple of 27.3 versus a 30.6 sector average, below the peer group. Analyst price targets sit 26.4% above the current price. Revenue is growing at 17.3% on a 6.9% profit margin. The 0.15% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 23.5%, a beta of -0.02 and a maximum drawdown of 31.8%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 5/10 conviction over the longer horizon.
On valuation the read is undervalued — earnings multiple of 27.3 versus a 30.6 sector average, below the peer group. Analyst price targets sit 26.4% above the current price. Revenue is growing at 17.3% on a 6.9% profit margin. The 0.15% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 23.5%, a beta of -0.02 and a maximum drawdown of 31.8%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 5/10 conviction over the longer horizon.
Top Market Events
Healthcare services company The Ensign Group NASDAQ:ENSG .Shares of healthcare services company The Ensign Group NASDAQ:ENSG .Raises 2026 Annual Earnings and Revenue Guidance; Conference Call and Webcast scheduled for July 29, 2026 at 10:00 am...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 182.43
- MACD momentum is negative
- Maximum drawdown of 31.8%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 27.3 versus sector average of 30.6
- Trading below the 200-day average of 182.43
- Analyst targets imply +26.4% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 27.3 versus sector average of 30.6
- Analyst targets imply +26.4% versus the current price
- Revenue growth of +17.3%
Key Metrics & Analysis
Financial Health
Revenue Growth17.30%
Profit Margin6.90%
P/E Ratio27.3
ROE16.97%
ROA5.49%
Debt/Equity92.03
P/B Ratio4.1
Op. Cash Flow$608.4M
Free Cash Flow$280.6M
Industry P/E30.6
Technical Analysis
TrendNeutral
RSI43.3
Support$170.00
Resistance$185.90
MA 20$179.51
MA 50$173.83
MA 200$182.43
MACDBearish
VolumeStable
Fear & Greed Index94.16
Valuation
Fair Value$91.73
Target Price$220.00
Upside/Downside26.43%
GradeUndervalued
TypeGrowth
Dividend Yield0.15%
Risk Assessment
Beta-0.02
Volatility23.53%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.